Hepatobiliary MR contrast agents are useful to diagnose hepatocellular carcinoma in patients with Budd-Chiari syndrome

BACKGROUND & AIMS: Hepatobiliary phase (HBP) images can discriminate between benign and malignant liver lesions, but it is unclear if this approach can be used in patients with Budd-Chiari syndrome (BCS). Thus, we aimed to assess the diagnostic utility of HBP images in patients with BCS. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Van Wettere, Morgane, Paulatto, Luisa, Raynaud, Lucas, Bruno, Onorina, Payancé, Audrey, Plessier, Aurélie, Rautou, Pierre-Emmanuel, Paradis, Valérie, Cazals-Hatem, Dominique, Valla, Dominique, Vilgrain, Valérie, Ronot, Maxime
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7232085/
https://www.ncbi.nlm.nih.gov/pubmed/32435753
http://dx.doi.org/10.1016/j.jhepr.2020.100097

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7232085/
https://www.ncbi.nlm.nih.gov/pubmed/32435753
http://dx.doi.org/10.1016/j.jhepr.2020.100097

Ejemplares similares